Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

NCT06589089 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: autologous hematopoietic stem cell

Sponsor

Ruijin Hospital